Mild Autonomous Cortisol Secretion vs. Cushing Syndrome: Key Differences
The fundamental difference is that mild autonomous cortisol secretion (MACS) represents biochemical cortisol excess without the classic clinical signs of Cushing syndrome, while overt Cushing syndrome presents with clinically apparent stigmata of hypercortisolism such as facial plethora, wide purple striae, proximal muscle weakness, and easy bruising. 1
Clinical Presentation
MACS patients lack the pathognomonic features of Cushing syndrome. They do not exhibit:
- Reddish purple striae (>1 cm wide)
- Facial plethora
- Proximal muscle weakness or wasting
- Easy bruising without trauma
- Supraclavicular fat pads
- Dorsocervical fat pad ("buffalo hump")
- Thin, fragile skin 2
In contrast, overt Cushing syndrome patients display multiple specific clinical stigmata that make the diagnosis clinically recognizable, though the spectrum can range from subtle to florid presentation 3, 2.
Biochemical Differences
Diagnostic Thresholds
For MACS:
- Post-1mg dexamethasone suppression test: cortisol >1.8 μg/dL (50 nmol/L) but typically <5 μg/dL (138 nmol/L) 1, 4
- 24-hour urinary free cortisol: normal or mildly elevated (≤1.5 times upper limit of normal) 5
- Midnight salivary cortisol: may be mildly elevated
- ACTH: often suppressed in adrenal causes 1
For overt Cushing syndrome:
- Post-1mg dexamethasone suppression test: cortisol typically >5 μg/dL (138 nmol/L) 4
- 24-hour urinary free cortisol: clearly elevated (>1.5 times upper limit of normal, often >4 times for definitive diagnosis) 6, 5
- Midnight salivary cortisol: markedly elevated
- Loss of diurnal cortisol rhythm 2
Importantly, pituitary Cushing patients demonstrate significantly higher 24-hour urinary cortisol levels compared to adrenal Cushing and MACS patients, likely due to high-amplitude ACTH stimulation 7.
Associated Comorbidities
Both conditions share similar metabolic complications, but the severity differs:
MACS is associated with:
- Type 2 diabetes mellitus
- Hypertension
- Cardiovascular events
- Vertebral fractures
- Dyslipidemia
- Increased mortality 1, 8
Critically, even mild cortisol excess in MACS is sufficient to establish these comorbidities 7. The degree of metabolic derangement correlates with cortisol levels, with alanine aminotransferase, triglycerides, VLDL, insulin, and basal cortisol significantly more elevated in overt Cushing compared to MACS 7.
Natural History
A crucial distinguishing feature: MACS does not progress to overt Cushing syndrome. Systematic reviews show no patients with failed cortisol suppression progressed to clinically apparent Cushing syndrome 1. This fundamentally changes the management approach—MACS should be regarded as having low risk of progression to overt disease but still contributes significantly to medical comorbidity 1.
Management Implications
Overt Cushing Syndrome
Surgical resection is mandatory for patients with clinically apparent Cushing syndrome and unilateral cortisol-secreting adrenal masses. Minimally invasive surgery should be performed when feasible 1, 3.
MACS
Management requires individualized decision-making:
- Consider adrenalectomy for: younger patients with progressive metabolic comorbidities attributable to cortisol excess, particularly those with suppressed ACTH 1, 6
- Conservative management: annual clinical screening for new or worsening comorbidities, with aggressive treatment of hypertension, diabetes, and dyslipidemia 1, 4
Patients with MACS and elevated hair cortisone (a marker of tissue cortisol exposure) require more antihypertensive treatments and show worse lipid profiles, suggesting this biomarker may help identify those who would benefit most from intervention 5.
Post-operative Considerations
Duration of adrenal insufficiency differs significantly:
- MACS: median recovery time 3.9 months (95% CI: 3.3-6.2)
- Overt Cushing syndrome: median recovery time 13.5 months (95% CI: 11.3-18.3) 9
Perioperative steroid coverage is essential for both conditions, but the duration of replacement therapy varies based on pre-operative cortisol levels and clinical severity 10, 9.
Diagnostic Algorithm
- Screen all adrenal incidentalomas with 1mg overnight dexamethasone suppression test 1
- If cortisol >1.8 μg/dL: assess for clinical signs of Cushing syndrome
- Clinical signs present: diagnose overt Cushing syndrome, proceed to surgical evaluation
- No clinical signs but cortisol >1.8 μg/dL: diagnose MACS, evaluate for cortisol-related comorbidities
- For MACS: screen for hypertension, diabetes, dyslipidemia, and osteoporosis; consider adrenalectomy in younger patients with progressive metabolic disease 1, 4